Last reviewed · How we verify

NCT06777134

Relationship Between Pelvic Floor Dysfunctions and Lower Limb Strength and Activation in MS Patients

Recruiting now Last updated 20 February 2026
What this trial tests

trial testing Assessment of pelvic floor dysfunction in Multiple Sclerosis in 73 participants. Currently enrolling.

Timeline
1 January 2025
Primary endpoint
10 December 2026
10 January 2027

Quick facts

Lead sponsorBerivan Beril Kılıç
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment73
Start date1 January 2025
Primary completion10 December 2026
Estimated completion10 January 2027
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Berivan Beril Kılıç

Who can join

Adults 18 to 65, female only, with Multiple Sclerosis or Pelvic Floor Dysfunction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

we aim to investigate the relationship between pelvic floor dysfunctions, core endurance, hip external rotation muscle strength, and tibialis posterior and tibialis anterior muscle activation in patients diagnosed with MS

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Multiple Sclerosis

Currently open trials in the same condition.

Other Berivan Beril Kılıç trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06777134.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing